AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 80 filers reported holding AKERO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $169,134,000 | +0.4% | 5,830,203 | 0.0% | 18.83% | +44.8% |
Q4 2020 | $168,435,000 | -6.2% | 5,830,203 | 0.0% | 13.00% | -46.3% |
Q3 2020 | $179,512,000 | +33.0% | 5,830,203 | +7.7% | 24.20% | -5.5% |
Q2 2020 | $134,947,000 | +17.5% | 5,415,203 | 0.0% | 25.62% | +11.4% |
Q1 2020 | $114,802,000 | -4.5% | 5,415,203 | 0.0% | 23.00% | +14.0% |
Q4 2019 | $120,163,000 | – | 5,415,203 | – | 20.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |